0001654954-23-000345.txt : 20230112 0001654954-23-000345.hdr.sgml : 20230112 20230112114532 ACCESSION NUMBER: 0001654954-23-000345 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230112 FILED AS OF DATE: 20230112 DATE AS OF CHANGE: 20230112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GSK PLC CENTRAL INDEX KEY: 0001131399 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15170 FILM NUMBER: 23525367 BUSINESS ADDRESS: STREET 1: 980 GREAT WEST ROAD CITY: BRENTFORD MIDDLESEX STATE: X0 ZIP: TW8 9GS BUSINESS PHONE: 011442080475000 MAIL ADDRESS: STREET 1: 980 GREAT WEST ROAD CITY: BRENTFORD MIDDLESEX STATE: X0 ZIP: TW8 9GS FORMER COMPANY: FORMER CONFORMED NAME: GLAXOSMITHKLINE PLC DATE OF NAME CHANGE: 20010105 6-K 1 a5834m.htm DIRECTOR/PDMR SHAREHOLDING a5834m
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of January 2023
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
 
 
 
GSK plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Ms E Walmsley
 
b)
Position/status
Chief Executive Officer
 
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
9 (partnership shares)
 
 
£14.1719
 
9 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
 
18 Ordinary Shares
£14.1719
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Mr J Ford  
b)
Position/status
 
SVP and Group General Counsel, Legal and Compliance
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
9 (partnership shares)
 
 
£14.1719
 
9 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
18 Ordinary Shares
£14.1719
 
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Ms S Jackson
b)
Position/status
 
SVP, Global Communications and CEO Office
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
9 (partnership shares)
 
 
£14.1719
 
9 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
18 Ordinary Shares
£14.1719
 
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Mr D Jackson
b)
Position/status
 
PCA of Ms S Jackson (SVP, Global Communications and CEO Office)
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
8 (partnership shares)
 
 
£14.1719
 
8 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
16 Ordinary Shares
£14.1719
 
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Mr D Redfern
b)
Position/status
 
President Corporate Development
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
9 (partnership shares)
 
 
£14.1719
 
9 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
18 Ordinary Shares
£14.1719
 
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Mr R Simard
b)
Position/status
 
President, Global Supply Chain
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
 
Acquisition of Ordinary Shares under the Company's Share Reward Plan
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
9 (partnership shares)
 
 
£14.1719
 
9 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
 
18 Ordinary Shares
£14.1719
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Mr P Thomson
b)
Position/status
 
President, Global Affairs
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
9 (partnership shares)
 
 
£14.1719
 
9 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
 
18 Ordinary Shares
£14.1719
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Ms D Waterhouse
 
b)
Position/status
CEO, ViiV Healthcare and President, Global Health, GSK
 
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
8 (partnership shares)
 
 
£14.1719
 
8 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
16 Ordinary Shares
£14.1719
 
e)
Date of the transaction
 
2023-01-11
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Ms V Whyte
b)
Position/status
 
Company Secretary
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Acquisition of Ordinary Shares under the Company's Share Reward Plan
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.1719
 
9 (partnership shares)
 
 
£14.1719
 
9 (matching shares)
 
 
 
 
 
d)
Aggregated information
 
 
 
Aggregated volume
Price
18 Ordinary Shares
£14.1719
 
e)
Date of the transaction
2023-01-11
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
This information is pro
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: January 12, 2023
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc